Aspira Women's Health, Inc. (AWHL)
0.2436
+0.01
(+2.44%)
USD |
OTCM |
Oct 05, 16:00
Aspira Women's Health Cash from Operations (Quarterly) : -2.01M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.01M |
| March 31, 2026 | -0.359M |
| December 31, 2025 | -1.981M |
| September 30, 2025 | -0.212M |
| June 30, 2025 | -1.734M |
| March 31, 2025 | -3.102M |
| December 31, 2024 | -1.021M |
| September 30, 2024 | -2.92M |
| June 30, 2024 | -3.741M |
| March 31, 2024 | -4.431M |
| December 31, 2023 | -3.45M |
| September 30, 2023 | -3.321M |
| June 30, 2023 | -3.417M |
| March 31, 2023 | -5.706M |
| December 31, 2022 | -7.076M |
| September 30, 2022 | -7.515M |
| June 30, 2022 | -6.304M |
| March 31, 2022 | -10.17M |
| December 31, 2021 | -7.649M |
| September 30, 2021 | -8.001M |
| June 30, 2021 | -6.49M |
| March 31, 2021 | -5.255M |
| December 31, 2020 | -4.757M |
| September 30, 2020 | -3.067M |
| June 30, 2020 | -3.409M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.501M |
| December 31, 2019 | -2.872M |
| September 30, 2019 | -3.442M |
| June 30, 2019 | -3.544M |
| March 31, 2019 | -3.108M |
| December 31, 2018 | -2.298M |
| September 30, 2018 | -2.293M |
| June 30, 2018 | -2.419M |
| March 31, 2018 | -2.357M |
| December 31, 2017 | -2.152M |
| September 30, 2017 | -1.786M |
| June 30, 2017 | -1.77M |
| March 31, 2017 | -2.421M |
| December 31, 2016 | -2.764M |
| September 30, 2016 | -2.744M |
| June 30, 2016 | -3.46M |
| March 31, 2016 | -4.995M |
| December 31, 2015 | -4.585M |
| September 30, 2015 | -4.313M |
| June 30, 2015 | -4.942M |
| March 31, 2015 | -4.525M |
| December 31, 2014 | -4.21M |
| September 30, 2014 | -5.344M |
| June 30, 2014 | -3.749M |
| March 31, 2014 | -3.505M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 347.16M |
| Neogen Corp. | 30.20M |
| QuidelOrtho Corp. | -110.60M |
| VolitionRX Ltd. | -4.993M |
| Lucid Diagnostics, Inc. | -11.30M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.15M |
| Cash from Financing (Quarterly) | 1.293M |
| Free Cash Flow | -5.113M |
| Free Cash Flow Per Share (Quarterly) | -0.0488 |
| Free Cash Flow to Equity (Quarterly) | -1.004M |
| Free Cash Flow to Firm (Quarterly) | -1.933M |
| Free Cash Flow Yield | -49.42% |